1863 related articles for article (PubMed ID: 18439601)
1. Short coasting of 1 or 2 days by withholding both gonadotropins and gonadotropin-releasing hormone agonist prevents ovarian hyperstimulation syndrome without compromising the outcome.
Moon HS; Joo BS; Moon SE; Lee SK; Kim KS; Koo JS
Fertil Steril; 2008 Dec; 90(6):2172-8. PubMed ID: 18439601
[TBL] [Abstract][Full Text] [Related]
2. The optimal length of 'coasting protocol' in women at risk of ovarian hyperstimulation syndrome undergoing in vitro fertilization.
Nardo LG; Cheema P; Gelbaya TA; Horne G; Fitzgerald CT; Pease EH; Brison DR; Lieberman BA
Hum Fertil (Camb); 2006 Sep; 9(3):175-80. PubMed ID: 17008270
[TBL] [Abstract][Full Text] [Related]
3. Oocyte quality and IVF outcome after coasting to prevent ovarian hyperstimulation syndrome.
Delvigne A; Kostyla K; Murillo D; Van Hoeck J; Rozenberg S
Int J Fertil Womens Med; 2003; 48(1):25-31. PubMed ID: 12643517
[TBL] [Abstract][Full Text] [Related]
4. Clinical and endocrine response to the withdrawal of gonadotropin-releasing hormone agonists during prolonged coasting.
Ho Yuen B; Nguyen TA; Cheung AP; Leung PC
Fertil Steril; 2009 Aug; 92(2):499-507. PubMed ID: 18706551
[TBL] [Abstract][Full Text] [Related]
5. Does coasting, a procedure to avoid ovarian hyperstimulation syndrome, affect assisted reproduction cycle outcome?
Yilmaz N; Uygur D; Ozgu E; Batioglu S
Fertil Steril; 2010 Jun; 94(1):189-93. PubMed ID: 19376515
[TBL] [Abstract][Full Text] [Related]
6. In vitro fertilization cycle outcome after coasting in gonadotropin-releasing hormone (GnRH) agonist versus GnRH antagonist protocols.
Farhi J; Ben-Haroush A; Lande Y; Sapir O; Pinkas H; Fisch B
Fertil Steril; 2009 Feb; 91(2):377-82. PubMed ID: 18321490
[TBL] [Abstract][Full Text] [Related]
7. The effect of withholding gonadotropin (a coasting period) on the outcome of in vitro fertilization cycles.
Owj M; Tehrani Nejad ESh; Amirchaghmaghi E; Ezabadi Z; Baghestani AR
Eur J Obstet Gynecol Reprod Biol; 2007 Jul; 133(1):81-5. PubMed ID: 17229513
[TBL] [Abstract][Full Text] [Related]
8. Predictors of success during the coasting period in high-responder patients undergoing controlled ovarian stimulation for assisted conception.
Ulug U; Ben-Shlomo I; Bahceci M
Fertil Steril; 2004 Aug; 82(2):338-42. PubMed ID: 15302281
[TBL] [Abstract][Full Text] [Related]
9. Withholding gonadotropins until human chorionic gonadotropin administration.
Abdallah R; Kligman I; Davis O; Rosenwaks Z
Semin Reprod Med; 2010 Nov; 28(6):486-92. PubMed ID: 21082507
[TBL] [Abstract][Full Text] [Related]
10. Gonadotropin-releasing hormone agonist to induce final oocyte maturation prevents the development of ovarian hyperstimulation syndrome in high-risk patients and leads to improved clinical outcomes compared with coasting.
DiLuigi AJ; Engmann L; Schmidt DW; Maier DB; Nulsen JC; Benadiva CA
Fertil Steril; 2010 Aug; 94(3):1111-4. PubMed ID: 20074722
[TBL] [Abstract][Full Text] [Related]
11. Triggering ovulation with gonadotropin-releasing hormone agonist in in vitro fertilization patients with polycystic ovaries does not cause ovarian hyperstimulation syndrome despite very high estradiol levels.
Manzanares MA; Gómez-Palomares JL; Ricciarelli E; Hernández ER
Fertil Steril; 2010 Mar; 93(4):1215-9. PubMed ID: 19200978
[TBL] [Abstract][Full Text] [Related]
12. Effect of coasting on IVF cycle characteristics and outcome in short vs. long GnRH agonist protocols.
Farhi J; Fisch B; Sapir O; Pinkas H; Ben-Haroush A
Gynecol Endocrinol; 2010 Mar; 26(3):187-92. PubMed ID: 20148740
[TBL] [Abstract][Full Text] [Related]
13. Ovarian response and pregnancy outcome in poor-responder women: a randomized controlled trial on the effect of luteinizing hormone supplementation on in vitro fertilization cycles.
Barrenetxea G; Agirregoikoa JA; Jiménez MR; de Larruzea AL; Ganzabal T; Carbonero K
Fertil Steril; 2008 Mar; 89(3):546-53. PubMed ID: 17531989
[TBL] [Abstract][Full Text] [Related]
14. The J-Tip Needle-Free Injection System in controlled ovarian hyperstimulation in in vitro fertilization: a pilot study.
Lavery SA; El-Shawarby SA; Turner C; Trew G
Fertil Steril; 2008 Nov; 90(5):1969-72. PubMed ID: 18166182
[TBL] [Abstract][Full Text] [Related]
15. Criteria of a successful coasting protocol for the prevention of severe ovarian hyperstimulation syndrome.
Mansour R; Aboulghar M; Serour G; Amin Y; Abou-Setta AM
Hum Reprod; 2005 Nov; 20(11):3167-72. PubMed ID: 16006465
[TBL] [Abstract][Full Text] [Related]
16. Serum estradiol levels during controlled ovarian hyperstimulation influence the pregnancy outcome of in vitro fertilization in a concentration-dependent manner.
Joo BS; Park SH; An BM; Kim KS; Moon SE; Moon HS
Fertil Steril; 2010 Feb; 93(2):442-6. PubMed ID: 19394001
[TBL] [Abstract][Full Text] [Related]
17. Ovarian hyperstimulation syndrome prevention by gonadotropin-releasing hormone agonist triggering of final oocyte maturation in a gonadotropin-releasing hormone antagonist protocol in combination with a "freeze-all" strategy: a prospective multicentric study.
Griesinger G; Schultz L; Bauer T; Broessner A; Frambach T; Kissler S
Fertil Steril; 2011 May; 95(6):2029-33, 2033.e1. PubMed ID: 21371705
[TBL] [Abstract][Full Text] [Related]
18. Triggering with human chorionic gonadotropin or a gonadotropin-releasing hormone agonist in gonadotropin-releasing hormone antagonist-treated oocyte donor cycles: findings of a large retrospective cohort study.
Bodri D; Guillén JJ; Galindo A; Mataró D; Pujol A; Coll O
Fertil Steril; 2009 Feb; 91(2):365-71. PubMed ID: 18367175
[TBL] [Abstract][Full Text] [Related]
19. [Clinical application of gonadotropin-releasing hormone antagonist in Chinese women undergoing controlled ovarian hyperstimulation for in vitro fertilization and embryo transfer].
Chen SL; Yin MN; Sun L; Li H; Chen X; Song HD; He JX; Zhu L; Xing FQ
Nan Fang Yi Ke Da Xue Xue Bao; 2007 May; 27(5):588-90. PubMed ID: 17545062
[TBL] [Abstract][Full Text] [Related]
20. Reducing the dose of human chorionic gonadotropin in high responders does not affect the outcomes of in vitro fertilization.
Schmidt DW; Maier DB; Nulsen JC; Benadiva CA
Fertil Steril; 2004 Oct; 82(4):841-6. PubMed ID: 15482757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
